286946-66-5 Usage
Description
(1R,5R)-benzyl 3-oxo-2,6-diazabicyclo[3.2.1]octane-6-carboxylate is a complex organic compound featuring a benzyl group attached to a 3-oxo-2,6-diazabicyclo[3.2.1]octane-6-carboxylate molecule. It is a derivative of a bicyclic amine and carboxylic acid, characterized by its two chiral centers that result in four possible stereoisomers. (1R,5R)-benzyl 3-oxo-2,6-diazabicyclo[3.2.1]octane-6-carboxylate is a versatile chemical building block with potential applications in pharmaceutical research and organic synthesis.
Uses
Used in Pharmaceutical Research:
(1R,5R)-benzyl 3-oxo-2,6-diazabicyclo[3.2.1]octane-6-carboxylate is used as a chemical intermediate for the development of new pharmaceuticals. Its unique stereochemistry and complex structure make it a promising candidate for the synthesis of novel drug molecules with potential therapeutic applications.
Used in Organic Synthesis:
In the field of organic synthesis, (1R,5R)-benzyl 3-oxo-2,6-diazabicyclo[3.2.1]octane-6-carboxylate serves as a key building block for the creation of various organic compounds. Its versatility allows for its incorporation into a wide range of chemical reactions, facilitating the synthesis of complex organic molecules with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 286946-66-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,6,9,4 and 6 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 286946-66:
(8*2)+(7*8)+(6*6)+(5*9)+(4*4)+(3*6)+(2*6)+(1*6)=205
205 % 10 = 5
So 286946-66-5 is a valid CAS Registry Number.
286946-66-5Relevant articles and documents
Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof
-
Page/Page column 67, (2011/04/18)
Provided herein are fused imidazolyl compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metabolic disorders. Compounds provided herein inhibit the activity of histamine H3 receptors and modulate the release of various neurotransmitters, such as, e.g., histamine, acetylcholine, norepinephrine, and dopamine (e.g. at the synapse). Pharmaceutical compositions containing the compounds and their methods of use are also provided herein.
Substituted diazabicycloalkane derivatives
-
Page/Page column 31, (2010/02/11)
Compounds of formula (I) [in-line-formulae]Z-Ar1—Ar2??(I) [/in-line-formulae] wherein Z is a diazabicyclic amine, Ar1 is a 5- or 6-membered aromatic ring, and Ar2 is selected from the group consisting of an unsubstituted or substituted 5- or 6-membered heteroaryl ring; unsubstituted or substituted bicyclic heteroaryl ring; 3,4-(methylenedioxy)phenyl; carbazolyl; tetrahydrocarbazolyl; naphthyl; and phenyl; wherein the phenyl is substituted with 0, 1, 2, or 3 substituents in the meta- or para-positions. The compounds are useful in treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods for using such compounds and compositions.